Targeted disruption of the JAK2/STAT3 pathway in combination with systemic administration of paclitaxel inhibits the priming of ovarian cancer stem-like cells leading to a reduced tumor burden

Khalid Abubaker(St Vincent's Hospital)

DOAJ (DOAJ: Directory of Open Access Journals)

April 1, 2014

10.3389/fonc.2014.00075

Cited by 78

Related Papers

Short-term single treatment of chemotherapy results in the enrichment of ovarian cancer stem cell-like cells leading to an increased tumor burden

|Molecular Cancer|2013|226

Inhibition of the JAK2/STAT3 pathway in ovarian cancer results in the loss of cancer stem cell-like characteristics and a reduced tumor burden

|BMC Cancer|2014|125

Targeted Disruption of the JAK2/STAT3 Pathway in Combination with Systemic Administration of Paclitaxel Inhibits the Priming of Ovarian Cancer Stem Cells Leading to a Reduced Tumor Burden

|Frontiers in Oncology|2014|9